ArticleWorld journal of diabetes2025
Trends and predictors of diabetes mellitus after living kidney transplantation: A retrospective study.
Article in World journal of diabetes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPost-transplant diabetes mellitus (PTDM) is a common metabolic adverse event following kidney transplantation, negatively impacting graft function and patient outcomes.
aimTo evaluate the frequency of PTDM and to determine predictive factors in living donor individuals who have undergone kidney transplantation.
methodsA retrospective analysis was conducted on 1200 living donor kidney transplant recipients treated between 2016 and 2023. Demographic, clinical, and treatment data were collected, and PTDM was identified based on American Diabetes Association criteria. Statistical analysis included logistic regression analysis to determine independent predictors of PTDM.
resultsPTDM was diagnosed in 162 patients (13.5%). Risk factors included older age [odds ratio (OR) 1.03,
conclusionPTDM remains a significant concern in kidney transplantation, particularly among patients with modifiable risk factors. Optimizing immunosuppressive regimens, implementing early metabolic monitoring, and addressing modifiable risks such as BMI may help reduce PTDM incidence. Additional research is required to evaluate extended-term results and refine preventive strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.